2019 KSNO指南:成人WHO Ⅲ级脑胶质瘤(v.2019.1)

2019-10-07 国外神经外科相关专家小组(统称) Brain Tumor Res Treat. 2019 Oct;7(2):63-73.

2019年10月,韩国神经肿瘤学学会(KSNO)发布了成人WHO Ⅲ级脑胶质瘤指南2019年v1版。专家组建议成人WHO Ⅲ级脑胶质瘤应接受最大安全性切除治疗,随后依据肿瘤的分子和组织学特征进行放射治疗和/或化疗。

中文标题:

2019 KSNO指南:成人WHO Ⅲ级脑胶质瘤(v.2019.1)

英文标题:

The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade III Cerebral Gliomas in Adults: Version 2019.01.

发布日期:

2019-10-07

简要介绍:

2019年10月,韩国神经肿瘤学学会(KSNO)发布了成人WHO Ⅲ级脑胶质瘤指南2019年v1版。专家组建议成人WHO Ⅲ级脑胶质瘤应接受最大安全性切除治疗,随后依据肿瘤的分子和组织学特征进行放射治疗和/或化疗。

 

拓展指南:脑胶质瘤相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 KSNO指南:成人WHO Ⅲ级脑胶质瘤(v.2019.1))] GetToolGuiderByIdResponse(projectId=1, id=108bb1c0018258c1, title=2019 KSNO指南:成人WHO Ⅲ级脑胶质瘤(v.2019.1), enTitle=The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade III Cerebral Gliomas in Adults: Version 2019.01., guiderFrom=Brain Tumor Res Treat. 2019 Oct;7(2):63-73., authorId=null, author=, summary=2019年10月,韩国神经肿瘤学学会(KSNO)发布了成人WHO Ⅲ级脑胶质瘤指南2019年v1版。专家组建议成人WHO Ⅲ级脑胶质瘤应接受最大安全性切除治疗,随后依据肿瘤的分子和组织学特征进行放射治疗和/或化疗。 , cover=, journalId=null, articlesId=null, associationId=1328, associationName=国外神经外科相关专家小组(统称), associationIntro=, copyright=0, guiderPublishedTime=Mon Oct 07 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年10月,韩国神经肿瘤学学会(KSNO)发布了成人WHO Ⅲ级脑胶质瘤指南2019年v1版。专家组建议成人WHO Ⅲ级脑胶质瘤应接受最大安全性切除治疗,随后依据肿瘤的分子和组织学特征进行放射治疗和/或化疗。 </P> <P> </P>拓展指南:<strong>与<font color=red>脑胶质瘤</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=223d81c00168017a" title="脑胶质瘤诊疗规范(2018年版)" target=_blank>脑胶质瘤诊疗规范(2018年版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=6b13c1c0010e75b8" title="2014 中国脑胶质瘤分子诊疗指南" target=_blank>2014 中国脑胶质瘤分子诊疗指南</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E8%84%91%E8%83%B6%E8%B4%A8%E7%98%A4" target=_blank>有关脑胶质瘤更多指南</a></ul>, tagList=[TagDto(tagId=8810, tagName=脑胶质瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=25, categoryName=神经外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6862, appHits=186, showAppHits=8, pcHits=4746, showPcHits=2817, likes=183, shares=7, comments=2, approvalStatus=1, publishedTime=Tue Nov 12 23:39:09 CST 2019, publishedTimeString=2019-10-07, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Nov 12 23:39:09 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 05:39:07 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 KSNO指南:成人WHO Ⅲ级脑胶质瘤(v.2019.1))])
2019 KSNO指南:成人WHO Ⅲ级脑胶质瘤(v.2019.1)
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1187847, encodeId=93e4118e84745, content=很及时, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f82d6481868, createdName=ms4000000282771868, createdTime=Mon Jan 24 22:17:09 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375106, encodeId=dd7b3e510637, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Wed Nov 13 05:57:33 CST 2019, time=2019-11-13, status=1, ipAttribution=)]
    2022-01-24 ms4000000282771868

    很及时

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1187847, encodeId=93e4118e84745, content=很及时, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f82d6481868, createdName=ms4000000282771868, createdTime=Mon Jan 24 22:17:09 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375106, encodeId=dd7b3e510637, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Wed Nov 13 05:57:33 CST 2019, time=2019-11-13, status=1, ipAttribution=)]
    2019-11-13 thm112988

    0